David Reardon

43PUBLICATIONS

408CO-AUTHORS

Molecular targetsPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (43)

Sort by Publication Date:

|Jul 15, 2026

Erdafitinib in Patients With Advanced Solid Tumors With <i>FGFR</i> Alterations (RAGNAR): Results of Tumor-Specific Analyses and Secondary Cohorts.

|Jun 12, 2026

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|Jun 03, 2026

Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|May 22, 2026

Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

|May 11, 2026

A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma.

|Oct 08, 2025

Serial multiomics uncovers anti-glioblastoma responses not evident by routine clinical analyses.

Alexander L Ling, Jennifer Gantchev, Michael C Prabhu

Pageof 8

Frequent Collaborators

15 joint publications

Patrick Y Wen

13 joint publications

Keith Ligon

12 joint publications

E Antonio Chiocca

Raymond Y Huang

Lakshmi Nayak

Wenya Linda Bi

Timothy F Cloughesy

Gilbert Youssef

Mehdi Touat

Eudocia Q Lee

Frequent Collaborators

15 joint publications

Patrick Y Wen

13 joint publications

Keith Ligon

12 joint publications

E Antonio Chiocca

8 joint publications

Raymond Y Huang